Certara Services Archives

Blog

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…

Certara2025 年 9 月 5 日

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

– London, UK

Certara2025 年 9 月 4 日

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

Certara2025 年 9 月 3 日

On-Demand Webinar

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.

Certara2025 年 8 月 21 日

On-Demand Webinar

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…

Certara2025 年 8 月 18 日

Case Study

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…

Certara2025 年 8 月 18 日

Conference

BioTechX US 2025

– – Booth

Simona Colucci2025 年 8 月 15 日

Publication

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

Certara2025 年 8 月 13 日

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

Certara2025 年 8 月 13 日

On-Demand Webinar

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Access our on-demand webinar to explore the key differences between eCTD 4.0 and eCTD 3.2.2.…

Certara2025 年 8 月 11 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

BioTechX US 2025

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

订阅时事通讯

快捷链接

解决方案

联系我们